Question 1

Does Goldman Sachs Group own TGTX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs Group holds 2,314,279 shares of TGTX (TG Therapeutics), worth $127.1M.

Question 2

How many shares of TGTX does Goldman Sachs Group own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group holds 2,314,279 shares of TGTX (TG Therapeutics).

Question 3

What is Goldman Sachs Group's TGTX position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group's TGTX position is worth $127.1M.

Question 4

Is Goldman Sachs Group buying or selling TGTX?

Accepted Answer

In Q2 2026, Goldman Sachs Group increased its TGTX position by 26,591 shares (+1.2%).

Question 5

When did Goldman Sachs Group first buy TGTX?

Accepted Answer

Goldman Sachs Group already held TGTX in its Q2 2022 13F, the earliest on record, and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.3M	+1.2%	$127.1M	0.0%	$54.94	30
2026-Q1	Increased	2.3M	+11.5%	$76M	0.0%	$33.22	33
2025-Q4	Increased	2.1M	+35.0%	$61.1M	0.0%	$29.81	38
2025-Q3	Decreased	1.5M	-3.2%	$54.9M	0.0%	$36.13	0
2025-Q2	Decreased	1.6M	-18.2%	$56.5M	0.0%	$35.99	0
2025-Q1	Increased	1.9M	+21.9%	$75.7M	0.0%	$39.43	36
2024-Q4	Decreased	1.6M	-38.4%	$47.4M	0.0%	$30.10	0
2024-Q3	Increased	2.6M	+22.6%	$59.8M	0.0%	$23.39	36